Glioblastoma: Why immunotherapy may offer hope for brain cancer patients

Published Date: 06 Nov 2024

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis?the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients survive beyond five years, ...

Read Full News

Latest News


News All Time

HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

2.

Clinical trial is testing whether heavy lifting could combat cancer side effects

3.

NIH research cuts leave cancer patient facing hard choice

4.

Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.

5.

A video animation guide to assist young people who are fatigued from cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot